New Immune Defense Mechanism Discovered: Antibody-Directed Xenophagy
Scientists discover new intracellular immune defense against infections
Image: Medical News
Researchers have identified a novel immune defense mechanism called antibody-directed xenophagy (ADX), which allows cells to digest pathogens like Salmonella and adenoviruses from within. This discovery, published in the journal Molecular Cell, highlights the role of the protein TRIM21 in marking and destroying these invaders, potentially leading to new therapeutic strategies against infections.
- 01Antibody-directed xenophagy (ADX) enables cells to digest pathogens that have entered them, marking a significant advancement in understanding immune responses.
- 02The protein TRIM21 plays a crucial role by tagging invading pathogens with ubiquitin, signaling their degradation.
- 03ADX is effective against various pathogens, including both viruses and bacteria, indicating its broad applicability in immune defense.
- 04The research demonstrated that TRIM21 is expressed widely in human cells, suggesting that ADX-mediated immunity is present throughout the body.
- 05Future research may explore additional proteins that stimulate ADX, which could lead to innovative treatments for infections.
Advertisement
In-Article Ad
A recent study published in the journal Molecular Cell reveals a new immune defense mechanism termed antibody-directed xenophagy (ADX), which allows cells to eliminate pathogens such as Salmonella and adenoviruses from within. Researchers from the MRC Laboratory of Molecular Biology discovered that the protein TRIM21 is crucial in this process, as it marks invading pathogens with ubiquitin, prompting their degradation. Unlike traditional immune responses that rely on antibodies in the bloodstream, ADX operates intracellularly, providing a vital line of defense when pathogens evade initial immune responses. The study indicates that TRIM21 is widely expressed across human cell lines and is upregulated during infections, suggesting that ADX is a common immune strategy. This discovery opens the door for potential therapeutic applications, where antibody or small molecule treatments could enhance TRIM21's ability to recognize and eliminate pathogens once they enter cells. Further research is needed to explore other proteins that may also stimulate ADX and to assess the limitations of TRIM21's function.
Advertisement
In-Article Ad
The discovery of ADX could lead to new therapeutic strategies for treating infections, potentially improving patient outcomes.
Advertisement
In-Article Ad
Reader Poll
What do you think about the potential of antibody-directed xenophagy in treating infections?
Connecting to poll...
Read the original article
Visit the source for the complete story.